United Therapeutics UTHR Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.33B+11.7% | $1.2B+21.4% | $984.8M+35.4% | $727.3M+52.9% | ||
| $85.6M+18.1% | $72.5M+36.3% | $53.2M+3.7% | $51.3M+2.8% | ||
| $147.7M+2.6% | $144M+268% | $39.1M-64.2% | $109.2M-21.2% | ||
| $1.56B+17.6% | $1.33B+35.7% | $978M+21.9% | $802.5M+34.2% | ||
| $520.5M+111% | $246.5M+7.0% | $230.4M+66.0% | $138.8M+14.9% | ||
| —— | —— | -$761.7M+6.1% | -$811.5M-66.7% | ||
| $1B— | —— | $0— | $0— | ||
| —— | $400M+300% | $100M— | —— | ||
| -$1.25B+0.5% | -$1.25B-10,445% | -$11.9M-116% | $75.4M+68.3% | ||
| —— | $489.5M— | —— | $72M— | ||
| $1.04B-3.7% | $1.08B+44.5% | $747.6M+12.6% | $663.7M+39.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does United Therapeutics generate?
- United Therapeutics (UTHR) generated $1.6B in operating cash flow over the trailing twelve months.
- What is United Therapeutics's free cash flow?
- After $546.4M of capital expenditures, United Therapeutics's free cash flow was $1.0B over the trailing twelve months, down 9.9% year over year.
- Where does United Therapeutics's cash flow data come from?
- Every line is extracted from United Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
